Sanara MedTech (SMTI) Liabilities and Shareholders Equity (2010 - 2026)

Sanara MedTech's Liabilities and Shareholders Equity history runs 16 years deep, the most recent figure standing at $69.3 million for Q1 2026.

• Quarterly Liabilities and Shareholders Equity fell 28.12% year-over-year to $69.3 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $312.1 million (down 9.91% YoY) and the FY2025 annual result came in at $72.9 million, down 17.2% from the prior year.
• Liabilities and Shareholders Equity was $69.3 million for Q1 2026 at Sanara MedTech, down from $72.9 million in the prior quarter.
• Across five years, Liabilities and Shareholders Equity topped out at $98.8 million in Q2 2025 and bottomed at $33.9 million in Q1 2022.
• A 5-year average of $71.4 million and a median of $72.9 million in 2025 frame the typical range for Liabilities and Shareholders Equity.
• Annual changes were most pronounced in 2023 — Liabilities and Shareholders Equity soared 76.72% — and 2026, when it dropped 28.12%.
• Sanara MedTech's Liabilities and Shareholders Equity stood at $61.0 million in 2022, then advanced by 21.03% to $73.9 million in 2023, then gained by 19.25% to $88.1 million in 2024, then decreased by 17.2% to $72.9 million in 2025, then dropped by 5.03% to $69.3 million in 2026.
• Business Quant data shows SMTI's Liabilities and Shareholders Equity at $69.3 million in Q1 2026, $72.9 million in Q4 2025, and $71.1 million in Q3 2025.